Clinical Trial Update: Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy [NA]

View source ↗

Summary

This clinical trial update reports the termination of a study in osteosarcoma evaluating doxorubicin with cisplatin, high-dose methotrexate, and additional risk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Doxorubicin (doxorubicin)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Osteosarcoma | NA | Status: TERMINATED | Results posted: 2014-09-10